Lipocine Inc.

General ticker "LPCN" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $29.5M (TTM average)

Lipocine Inc. does not follow the US Stock Market performance with the rate: -23.4%.

Estimated limits based on current volatility of 6.9%: low 1.46$, high 1.68$

Factors to consider:

  • Total employees count: 14 (-12.5%) as of 2025
  • Top business risk factors: Clinical trial delays, Regulatory and compliance, Commercialization failure, Inability to raise capital, Market competition
  • Current price 50.3% below estimated low
  • Earnings for 6 months up through Q2 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [3.14$, 7.84$]
  • 2026-12-31 to 2027-12-31 estimated range: [2.51$, 6.49$]

Financial Metrics affecting the LPCN estimates:

  • Negative: with PPE of -3.4 at the end of fiscal year the price was high
  • Negative: negative Operating income
  • Negative: negative Operating cash flow
  • Negative: negative Net income
  • Positive: Investing cash flow per share per price, % of 19.09 > 2.08
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Negative: Industry earnings per price (median), % of -15.99 <= 0

Similar symbols

Short-term LPCN quotes

Long-term LPCN plot with estimates

Financial data

YTD 2024-12-31 2025-12-31
Operating Revenue $11.20MM $1.98MM
Operating Expenses $12.35MM $12.35MM
Operating Income $-1.16MM $-10.37MM
Non-Operating Income $1.16MM $0.74MM
R&D Expense $7.35MM $8.58MM
Income(Loss) $0.01MM $-9.63MM
Taxes $0.00MM $0.00MM
Net Income(Loss)* $0.01MM $-9.63MM
Stockholders Equity $21.00MM $14.48MM
Assets $22.51MM $17.01MM
Operating Cash Flow $-1.22MM $-9.76MM
Capital expenditure $0.09MM $0.00MM
Investing Cash Flow $2.45MM $5.89MM
Financing Cash Flow $0.21MM $2.87MM
Earnings Per Share** $0.00 $-1.77

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.